Hyperbaric Oxygen Therapy in Complex Regional Pain Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Ostrava
About this trial
The aim of the study is to investigate the efficacy of hyperbaric oxygen therapy as an adjunct in the management of severe complex regional pain syndrome.
Eligibility criteria
Qualifiers
None
Disqualifiers
HBOT contraindications (pregnancy; use of bleomycin, cisplatin, disulfiram, and doxorubicin; middle ear surgery; untreated pneumothorax or pneumomediastinum; ongoing acute infection; severe decompensation of organ functions or organ failure, severe claustrophobia)
Inability to sign the consent form
Trial design
Treatments tested in this trial
- Early hyperbaric oxygen therapy (HBOT)
- Delayed hyperbaric oxygen therapy (HBOT)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov